Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Rang in aandelen #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Aandeelprijs
$0.158
Laatst gesynchroniseerd: 2026-04-06
Marktkapitalisatie
$302.92K
Verandering (1 dag)
16.18%
Verandering (1 jaar)
-97.91%
Land
US
Handel Abpro Corporation (ABP)

Categorie

Koersgeschiedenis voor Abpro Corporation (ABP)
Hoogste slotkoers: $0.15 op 2026-04-01

Laagste slotkoers: $111.21 op 2024-11-01
Koersgeschiedenis van Abpro Corporation van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -20.12%
2025 -91.12%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.40%
KR
$259.89 14.81%
BE